1989
DOI: 10.1530/jrf.0.0870301
|View full text |Cite
|
Sign up to set email alerts
|

Changing responsiveness of luteal cells of the marmoset monkey (Callithrix jacchus) to luteotrophic and luteolytic agents during normal and conception cycles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

1990
1990
2015
2015

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(9 citation statements)
references
References 16 publications
0
9
0
Order By: Relevance
“…A significant rise in serum gonadotrophin activity [measured by mouse Leydig cell activity, which reacts to both luteinizing hormone (LH) and CG] does not occur until the 17th day of pregnancy (Hearn et al, 1988). However, corpora lutea removed from the marmoset on the 14th day of pregnancy secreted more progesterone in culture than those from nonpregnant animals (Webley et al, 1989). Furthermore, Webley etal.…”
Section: Discussionmentioning
confidence: 95%
“…A significant rise in serum gonadotrophin activity [measured by mouse Leydig cell activity, which reacts to both luteinizing hormone (LH) and CG] does not occur until the 17th day of pregnancy (Hearn et al, 1988). However, corpora lutea removed from the marmoset on the 14th day of pregnancy secreted more progesterone in culture than those from nonpregnant animals (Webley et al, 1989). Furthermore, Webley etal.…”
Section: Discussionmentioning
confidence: 95%
“…The luteotrophic actions of PGF 2· appear to be luteal phase [2,16,17] and concentration-dependent [7]. These actions are reported to be strongest in the mid-luteal phase and during pregnancy of investigated species [11,[24][25][26]. Maximal luteotrophic responses to PGF 2· are reported at a concentration of PGF 2· which corresponds to the reported K d [12,13] of the PGF 2· receptor (approximately 1 nM) [7].…”
Section: Discussionmentioning
confidence: 99%
“…injection containing a mixture of ketamine (Parke Davis, USA; 5 mg/350 g body weight) and xylazine (Rompun, Bayer; 1 mg/350 g body weight), and narcotized with a halothane-nitrous oxideoxygen mixture (Baxter, Unterschleißheim, Germany). Laparotomy was performed, and the tissue was removed by luteectomy as described by Webley et al (1989). The CLs were staged retrospectively to the different luteal phases by plasma P 4 determination twice per week after ovulation, and the ensuing analysis of the plasma P 4 on the day of luteectomy.…”
Section: Tissue Collectionmentioning
confidence: 99%